Recent progress in the development of new antimalarial drugs with novel targets
TM Belete - Drug design, development and therapy, 2020 - Taylor & Francis
Malaria is a major global health problem that causes significant mortality and morbidity
annually. The therapeutic options are scarce and massively challenged by the emergence of …
annually. The therapeutic options are scarce and massively challenged by the emergence of …
[HTML][HTML] Artemisinin and multidrug-resistant Plasmodium falciparum–a threat for malaria control and elimination
M Dhorda, C Amaratunga… - Current opinion in …, 2021 - journals.lww.com
Enhancing the geographic coverage of surveillance for resistance will be key to ensure
prompt detection of emerging resistance in order to implement effective countermeasures …
prompt detection of emerging resistance in order to implement effective countermeasures …
Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors
Antimalarial drug resistance has thrown a spanner in the works of malaria elimination. New
drugs are required for ancillary support of existing malaria control efforts. Plasmodium …
drugs are required for ancillary support of existing malaria control efforts. Plasmodium …
Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay
Mechanisms of action (MoAs) have been elusive for most antimalarial drugs in clinical use.
Decreasing responsiveness to antimalarial treatments stresses the need for a better …
Decreasing responsiveness to antimalarial treatments stresses the need for a better …
[HTML][HTML] Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination
M Ouji, JM Augereau, L Paloque, F Benoit-Vical - Parasite, 2018 - ncbi.nlm.nih.gov
The use of artemisinin-based combination therapies (ACTs), which combine an artemisinin
derivative with a partner drug, in the treatment of uncomplicated malaria has largely been …
derivative with a partner drug, in the treatment of uncomplicated malaria has largely been …
Hijacking factor H for complement immune evasion
The complement system is an essential player in innate and adaptive immunity. It consists of
three pathways (alternative, classical, and lectin) that initiate either spontaneously …
three pathways (alternative, classical, and lectin) that initiate either spontaneously …
Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an …
J Landier, DM Parker, AM Thu, KM Lwin, G Delmas… - The Lancet, 2018 - thelancet.com
Summary Background Potentially untreatable Plasmodium falciparum malaria threatens the
Greater Mekong subregion. A previous series of pilot projects in Myanmar, Laos, Cambodia …
Greater Mekong subregion. A previous series of pilot projects in Myanmar, Laos, Cambodia …
Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants
Malaria—a parasite vector-borne disease—is a global health problem, and Plasmodium
falciparum has proven to be the deadliest among Plasmodium spp., which causes malaria in …
falciparum has proven to be the deadliest among Plasmodium spp., which causes malaria in …
Enhancing the antimalarial activity of artesunate
The global challenge to the treatment of malaria is mainly the occurrence of resistance of
malaria parasites to conventionally used antimalarials. Artesunate, a semisynthetic …
malaria parasites to conventionally used antimalarials. Artesunate, a semisynthetic …
Chloroquine and sulfadoxine–pyrimethamine resistance in Sub-Saharan Africa—A review
Malaria is a great concern for global health and accounts for a large amount of morbidity and
mortality, particularly in Africa, with sub-Saharan Africa carrying the greatest burden of the …
mortality, particularly in Africa, with sub-Saharan Africa carrying the greatest burden of the …